MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    Antidepressants in Huntington’s Disease: A Meta Analysis of Mood and Motor Outcomes with Placebo-controlled Trials

    J. Patino, J. Pitton Rissardo, A. Fornari Caprara, A. Mcgarry, I. Walker, N. Rocha, A. Duker, E. Furr Stimming (Cincinnati, USA)

    Objective: To evaluate the efficacy of antidepressants for depression in Huntington’s disease (HD). Background: Depression is highly prevalent in HD. Despite frequent clinical use of…
  • 2026 International Congress

    Lipid Alterations in Central Nervous System and Plasma During Early Stages of Parkinson’s Disease

    P. Thakur, U. Agarwal (Thiruvananthapuram, India)

    Objective: To identify early lipid alterations in a progressive mouse model of Parkinson’s disease (PD) and to determine whether peripheral lipid signatures reflect lipid changes…
  • 2026 International Congress

    Rare Neurotoxicity of Cotrimoxazole A Movement Disorder Presentation In Elderly Patient

    M. Keita Sr, A. Ouedraogo, E E. Fanorena, C. Bekara, M. Abdallah (Bourges, France)

    Objective: We report the case of an elderly woman with hyperkinetic movement disorders Background: Trimethoprim-sulfamethoxazole (TMP-SMX) is widely used for Pneumocystis jirovecii prophylaxis, but significant neurological toxicity…
  • 2026 International Congress

    Clinical Characteristics and Functional Impact of Tremor in Patients with Multiple Sclerosis in Nepal: A Cross-Sectional Observational Study

    AYU. Chandra, AVI. Chandra (Kathmandu, Nepal)

    Objective: To describe the clinical characteristics of tremor in multiple sclerosis (MS) patients in Nepal and assess its functional impact on daily living. To describe…
  • 2026 International Congress

    A Meta-analysis of Tonic Motor Activation (TOMAC) Therapy for Restless Legs Syndrome

    J. Pitton Rissardo, J. Patino, A. Fornari Caprara, A. Mcgarry, I. Walker (Camden, USA)

    Objective: To evaluate the efficacy and safety of Tonic Motor Activation (TOMAC) therapy for adults with restless legs syndrome (RLS). Background: TOMAC is a novel,…
  • 2026 International Congress

    Sex Differences in the Reported Prodromal Symptoms of Parkinson’s Disease (PD) in the Fox Insight Cohort

    Z. Zullali, E. Trinh, G. Stebbins, E. Brown, K. Harrison, C. Meng, X. Chen, D. Paredes, K. Comyns, M. Korell, C M. Tanner (San Francisco, USA)

    Objective: To identify differences in the self-reported prodromal symptoms of male vs female persons with PD (PwPD) in the Fox Insight (FI) cohort. Background: Early…
  • 2026 International Congress

    GLP1R Expression and Parkinson’s Disease and Related Disorders in GLP-1RA–Treated Type 2 Diabetes

    KA. Woo, Y. Jang, P. Park, HJ. Kim (Seoul, Republic of Korea)

    Objective: We tested whether interindividual differences in systemic GLP1R expression are associated with PDRD risk among adults with type 2 diabetes initiating GLP-1RAs. Background: Preclinical…
  • 2026 International Congress

    Gait parameters, Imaging features, and CSF tap test in idiopathic Normal Pressure Hydrocephalus (iNPH) Is composite testing the way to go

    A. Elavarasi, S. Poudel, A. Fasano, D. Dash, A. Wagle Shukla, A. Garg, A. Upadhyay, N. Wig, R. Rajan, A. Das, M. Tripathi, P. Chandra, A. Suri (New Delhi, India)

    Objective: To analyze the positive predictive values of specific imaging findings for CSF-TT responsiveness and shunt responsivenessTo determine whether composite diagnostic models incorporating CSF-TT and…
  • 2026 International Congress

    Subthalamic Nucleus Deep Brain Stimulation Modulates Cortical Activation During Kinesthetic Illusion in Parkinson’s Disease: An fMRI Study

    A. Vijayakumari, T. Gonzalez, C. Piccinin, P. Bhattacharyya, M. Lowe, B. Walter (Cleveland, USA)

    Objective: To investigate how subthalamic nucleus deep brain stimulation (STN-DBS) modulates cortical activation during kinesthetic illusion (KI) in Parkinson’s disease (PD). Background: There is increasing…
  • 2026 International Congress

    Sudomotor Dysfunction in Patients With Normal and Abnormal Cardiac MIBG

    Z. Jiang, G. Chiaro, V. Iodice (London, United Kingdom)

    Objective: We examined the pattern of sweat loss in patients with normal versus abnormal MIBG and considered the implications of this in predicting phenoconversion trajectory.…
  • « Previous Page
  • 1
  • …
  • 16
  • 17
  • 18
  • 19
  • 20
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley